Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2007 1
2008 1
2009 3
2012 2
2013 4
2014 3
2015 3
2016 6
2017 3
2018 9
2019 5
2020 5
2021 6
2022 4
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UK.
Vasiliadou I, Grose D, Wilson C, Thapa A, Donnelly O, Lee E, Leslie I, Karim M, Hartley A, Partridge S, Medlow K, De Boisanger J, Metcalf R, Williamson A, Haridass A, Noble D, Mactier K, Walter H, Ma N, De Winton E, Cohen J, Rayner L, Geropantas K, Jankowska P, Mason J, Moleron R, Laws K, Ulahannan D, Nallathambi C, Michaelidou A, Nallamilli S, Raouf S, Palmer K, Bienz M, Karet T, Khalique S, Paterson C, Harrington K, Bhide S, Kong A. Vasiliadou I, et al. Among authors: hartley a. Int J Cancer. 2024 Apr 29. doi: 10.1002/ijc.34963. Online ahead of print. Int J Cancer. 2024. PMID: 38685816
CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer.
Mehanna H, Gaunt P, Kong A, Hartley A, Sanghera P, Forster M, Sen M, Paleri V, Fong C, Geropantas D, Srinivasan D, Garikipati S, Moleron R, Casswell G, Aynsley E, Ward A, O'Toole L, Mirza A, Firth C, Humphreys I, Fulton-Lieuw T, Roques T, Nankivell P. Mehanna H, et al. Among authors: hartley a. Trials. 2024 Jan 15;25(1):50. doi: 10.1186/s13063-023-07881-1. Trials. 2024. PMID: 38221636 Free PMC article.
Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD).
Thomson DJ, Slevin NJ, Baines H, Betts G, Bolton S, Evans M, Garcez K, Irlam J, Lee L, Melillo N, Mistry H, More E, Nutting C, Price JM, Schipani S, Sen M, Yang H, West CM; NIMRAD Trial Group. Thomson DJ, et al. Int J Radiat Oncol Biol Phys. 2023 Dec 9:S0360-3016(23)08184-1. doi: 10.1016/j.ijrobp.2023.11.055. Online ahead of print. Int J Radiat Oncol Biol Phys. 2023. PMID: 38072326 Free article.
Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study.
Mehanna H, Rapozo D, von Zeidler SV, Harrington KJ, Winter SC, Hartley A, Nankivell P, Schache AG, Sloan P, Odell EW, Thavaraj S, Hunter KD, Shah KA, Thomas GJ, Long A, Amel-Kashipaz R, Brown RM, Conn B, Hall GL, Matthews P, Weir J, Yeo Y, Pring M, West CML, McCaul J, Golusinski P, Sitch A, Spruce R, Batis N, Bryant JL, Brooks JM, Jones TM, Buffa F, Haider S, Robinson M. Mehanna H, et al. Among authors: hartley a. Clin Cancer Res. 2024 Jan 17;30(2):356-367. doi: 10.1158/1078-0432.CCR-23-1013. Clin Cancer Res. 2024. PMID: 37870417 Free PMC article.
Patient preference for commonly-used, head and neck cancer-specific quality of life questionnaires in the follow-up setting (Determin): A multi-centre randomised controlled trial and mixed methods study.
Mehanna H, Carter B, Hartley A, Abou-Foul AK, Brooks J, Jones J, Fresco L, Moss L, Jones TM, Rogers SN, Morton RP; DETERMIN Study Management Group. Mehanna H, et al. Among authors: hartley a. Clin Otolaryngol. 2023 Jul;48(4):613-622. doi: 10.1111/coa.14054. Epub 2023 Apr 4. Clin Otolaryngol. 2023. PMID: 37014180 Clinical Trial.
Why are There not More Bayesian Clinical Trials? Ability to Interpret Bayesian and Conventional Statistics Among Medical Researchers.
Medical Outreach Team of the Drug Information Association Bayesian Scientific Working Group; Bray R, Hartley A, Wenkert D, Muehlemann N, Natanegara F, Harrell FE Jr, Wang F, Clark J. Medical Outreach Team of the Drug Information Association Bayesian Scientific Working Group, et al. Among authors: hartley a. Ther Innov Regul Sci. 2023 May;57(3):426-435. doi: 10.1007/s43441-022-00482-1. Epub 2022 Dec 10. Ther Innov Regul Sci. 2023. PMID: 36496452
Why are not There More Bayesian Clinical Trials? Perceived Barriers and Educational Preferences Among Medical Researchers Involved in Drug Development.
Medical Outreach Subteam of the Drug Information Association Bayesian Scientific Working Group; Clark J, Muhlemann N, Natanegara F, Hartley A, Wenkert D, Wang F, Harrell FE Jr, Bray R. Medical Outreach Subteam of the Drug Information Association Bayesian Scientific Working Group, et al. Among authors: hartley a. Ther Innov Regul Sci. 2023 May;57(3):417-425. doi: 10.1007/s43441-021-00357-x. Epub 2022 Jan 3. Ther Innov Regul Sci. 2023. PMID: 34978048 Free PMC article.
58 results